“ICMR cannot be associated with this poorly designed study,” Dr Rajiv Bahl wrote.
ICMR distances itself from controversial study questioning Covaxin safety, cites critical methodological flaws
“ICMR cannot be associated with this poorly designed study,” Dr Rajiv Bahl wrote.